Key result
This review provides a practical guide based on AHA recommendations for clinicians selecting diagnostic tests and stratifying risk in women with suspected stable ischemic heart disease.
Provides a practical guide based on AHA recommendations for selecting diagnostic tests in women with suspected stable ischemic heart disease.
May guide test selection and risk stratification in women with suspected stable ischemic heart disease; leaves open need for prospective validation of AHA-based approaches.
Ischemic heart disease (IHD) is the leading cause of death and disability among women in the United States. Identifying IHD in women presenting with stable symptoms and stratifying their risk for an IHD event can be challenging for providers, with several different tests available. This article is meant to serve as a practical guide for clinicians treating women with potentially ischemic symptoms. Evidence and American Heart Association (AHA) recommendations regarding test selection are reviewed, with a focus on the information to be gained from each test. We outline suggested courses of action to be taken in the case of a positive or negative test. Regardless of the initial test result, clinicians should view a woman's symptom presentation as an opportunity to review and modify her risk of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Reynolds et al. (2018) conducted a review in Suspected stable ischemic heart disease. Diagnostic test selection was evaluated. This review provides a practical guide based on AHA recommendations for clinicians selecting diagnostic tests and stratifying risk in women with suspected stable ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: